Biology subjects

Fink, D. M.

Publications and source records attributed to Fink, D. M..

3 recordsLinked to original sources

bioRxiv2026

Ift43 Controls the Ciliary Levels of Gli2 and Gli3

Intraflagellar transport (IFT) drives the bidirectional movement of trains composed of IFT-A, IFT-B, and BBSome complexes that build and maintain cilia while supporting their signaling functions. Over evolution, IFT became integral to Hedgehog signaling by directing the dynamic movements of receptors and Gli transcription factors that fine-tune pathway output. The IFT-A complex contains six subunits, but the smallest, Ift43, remains poorly characterized and is absent from many ciliated species, suggesting specialized roles in signaling rather than core ciliogenesis. Here we show that loss of Ift43 in mice causes mid-gestation lethality with severe craniofacial defects, exencephaly, abdominal wall defects with exposed viscera, edema, and limb patterning defects. At the cellular level, Ift43 deficiency reduces both the number and length of cilia and blocks induction of Gli1 following pathway activation by the agonist SAG. Although Smoothened relocalizes to cilia normally, Ift43 mutants abnormally accumulate Gli2 and Gli3 at ciliary tips before stimulation and continue to generate repressor forms after activation. Conversely, Ift43 overexpression increases basal Gli2 cleavage, revealing an unanticipated role for Ift43 in regulating Gli processing. Together, these findings identify Ift43 as a key IFT-A component that links ciliary assembly to Hedgehog signal transduction and helps set the balance between Gli activator and repressor forms.

cell biology↗

bioRxiv2025

Recapitulating physiologically relevant oxygen levels and extracellular matrix remodeling in patient-derived tumor-immune tunable models reveal targeting opportunities for immunologically cold high-grade serous tumors

High-grade serous tumors are immunologically cold, characterized by limited immune cell infiltration and reduced clinical outcome, primarily due to hypoxia and extensive extracellular matrix remodeling that disrupt tumor-stromal-immune interactions. However, current experimental models fail to fully capture oxygen and matrix microenvironmental features, limiting progress in understanding tumor-immune dynamics and developing effective treatments. Here, we demonstrate that patient-derived tumor-immune tunable models, mimicking physiologically relevant oxygen levels and extracellular matrix remodeling, recapitulate the hypoxia-induced stromal/matrix dysregulation, which causes impaired immune infiltration, and enable dissecting targeted opportunities via TGF-{beta} signaling. The models integrate cancer cells co-cultured with cancer-associated fibroblasts and exposed to immune cells as multi-culture or challenged them to infiltrate into a 3D model bioengineered with autologous plasma from the matching patient or onto decellularized human ovaries. By bioengineering physiologically relevant oxygen levels of hypoxic tumors and physoxic ovaries, we uncovered that intratumoral hypoxia acts as a friend and a foe, causing hypoxia-induced stromal-driven impaired immune infiltration but enhancing the activation and cytotoxicity of CD8+ T cells. We also showed that targeting TGF-{beta} signaling reversed the hypoxia-induced stromal-driven impaired immune infiltration. These human-relevant tunable models may aid the development of targeted therapies to turn immunologically cold tumors into hot ones.

bioengineering↗

bioRxiv2025

IFT20 regulates lymphatic endothelial cell-cell junctions via endocytic trafficking of VE-cadherin

Intraflagellar transport (IFT) proteins are required for the assembly and function of primary cilia. They also regulate non-ciliary polarized vesicular traffic, such as T cell receptor recycling. We recently reported that lymphatic endothelial cells assemble primary cilia and express IFT proteins. Here, we report that IFT20 regulates vascular endothelial cadherin (VE-cadherin) localization at adherens junctions. IFT20 deletion caused discontinuous, button-like interendothelial junctions. This resulted in excessive lymphangiogenesis and impaired lymph drainage in mice. In vitro, VEGF-C treatment of IFT20 KD primary human dermal lymphatic endothelial cells caused accumulation of VE-cadherin in RAB5+ endosomes and enhanced and sustained VEGFR-3 signaling. Our findings are consistent with a model in which IFT20 promotes recycling of VE-cadherin to the adherens junction where it sequesters VEGFR-3 at the cell surface, thereby limiting pro-lymphangiogenic signaling. In the absence of IFT20, intercellular junctions are destabilized, pro-lymphangiogenic VEGFR-3 signaling is enhanced, and lymph transport is impaired by intracellular sequestration of VE-cadherin. This study elucidates the function of an IFT protein in lymphatic endothelial cells and provides mechanistic insight into the processes that regulate lymphatic endothelial cell-cell junctions and lymphangiogenic signaling.

cell biology↗